Socioeconomic factors and use of secondary preventive therapies for cardiovascular diseases in South Asia: The PURE study

Abstract

The use of secondary preventive drug therapies in patients with known CHD or stroke in South Asia is low with over 80% receiving none of the effective drug treatments. Low household wealth is the most important determinant.